| Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines KT Akama, LI Thompson, TA Milner, BS McEwen Journal of Biological Chemistry 288 (9), 6438-6450, 2013 | 171 | 2013 |
| G-protein-coupled estrogen receptor 1 is anatomically positioned to modulate synaptic plasticity in the mouse hippocampus EM Waters, LI Thompson, P Patel, AD Gonzales, HZ Ye, EJ Filardo, ... Journal of Neuroscience 35 (6), 2384-2397, 2015 | 166 | 2015 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 164 | 2022 |
| Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward J Alber, D Goldfarb, LI Thompson, E Arthur, K Hernandez, D Cheng, ... Alzheimer's & Dementia 16 (1), 229-243, 2020 | 129 | 2020 |
| Distribution of estrogen receptor beta containing cells in the brains of bacterial artificial chromosome transgenic mice TA Milner, LI Thompson, G Wang, JA Kievits, E Martin, P Zhou, ... Brain research 1351, 74-96, 2010 | 86 | 2010 |
| Within-family conflict behaviors as predictors of conflict in adolescent romantic relations N Darling, CL Cohan, A Burns, L Thompson Journal of adolescence 31 (6), 671-690, 2008 | 63 | 2008 |
| Profiles of executive functioning: associations with substance dependence and risky sexual behavior. SA Golub, TJ Starks, WJ Kowalczyk, LI Thompson, JT Parsons Psychology of Addictive Behaviors 26 (4), 895, 2012 | 47 | 2012 |
| Characteristics of subjective cognitive decline associated with amyloid positivity O Janssen, WJ Jansen, SJB Vos, M Boada, L Parnetti, T Gabryelewicz, ... Alzheimer's & Dementia 18 (10), 1832-1845, 2022 | 43 | 2022 |
| A highly feasible, reliable, and fully remote protocol for mobile app‐based cognitive assessment in cognitively healthy older adults LI Thompson, KD Harrington, N Roque, J Strenger, S Correia, RN Jones, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 14 (1 …, 2022 | 39 | 2022 |
| Age-and hormone-regulation of opioid peptides and synaptic proteins in the rat dorsal hippocampal formation TJ Williams, KL Mitterling, LI Thompson, A Torres-Reveron, EM Waters, ... Brain research 1379, 71-85, 2011 | 31 | 2011 |
| A neuropsychological perspective on defining cognitive impairment in the clinical study of Alzheimer’s disease: Towards a more continuous approach RJ Jutten, L Thompson, SAM Sikkes, P Maruff, JL Molinuevo, H Zetterberg, ... Journal of Alzheimer's Disease 86 (2), 511-524, 2022 | 21 | 2022 |
| Biomarkers of Alzheimer’s disease: Past, present and future clinical use JE Georgakas, MD Howe, LI Thompson, NM Riera, MC Riddle Biomarkers in Neuropsychiatry 8, 100063, 2023 | 18 | 2023 |
| Dissociating statistically determined normal cognitive abilities and mild cognitive impairment subtypes with DCTclock EF Matusz, CC Price, M Lamar, R Swenson, R Au, S Emrani, ... Journal of the International Neuropsychological Society 29 (2), 148-158, 2023 | 16 | 2023 |
| Affective differences in Iowa Gambling Task performance associated with sexual risk taking and substance use among HIV-positive and HIV-negative men who have sex with men SA Golub, LI Thompson, WJ Kowalczyk Journal of clinical and experimental neuropsychology 38 (2), 141-157, 2016 | 16 | 2016 |
| Remote and in‐clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults LI Thompson, ZJ Kunicki, S Emrani, J Strenger, AN De Vito, KJ Britton, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (4 …, 2023 | 15 | 2023 |
| Developing retinal biomarkers for the earliest stages of Alzheimer’s disease: what we know, what we don’t, and how to move forward. Alzheimers Dement. 2020 J Alber, D Goldfarb, LI Thompson, E Arthur, K Hernandez, D Cheng | 14 | |
| A potential association between retinal changes, subjective memory impairment, and anxiety in older adults at risk for Alzheimer’s disease: a 27-month pilot study DL Cheng, L Thompson, PJ Snyder Frontiers in aging neuroscience 11, 288, 2019 | 13 | 2019 |
| Interclinician variation in diabetes foot assessment—a national lottery? L Thompson, C Nester, L Stuart, P Wiles Diabetic medicine 22 (2), 196-199, 2005 | 10 | 2005 |
| Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline. TEK Cersonsky, S Mechery, MM Carper, L Thompson, A Lee, J Alber, ... Neuropsychology 36 (5), 373, 2022 | 9 | 2022 |
| Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer’s disease after a … J Alber, P Maruff, CY Santos, BR Ott, SP Salloway, DC Yoo, RB Noto, ... Alzheimer's Research & Therapy 12, 1-9, 2020 | 8 | 2020 |
